A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits

Toxicology and Applied Pharmacology
S MannMarie Vahter

Abstract

A physiologically based pharmacokinetic model for exposure to inorganic arsenic in hamsters and rabbits has been developed. The model in its present state simulates three routes of exposure to inorganic arsenic: oral intake, intravenous injection, and intratracheal instillation. It describes the tissue concentrations and the urinary and fecal excretions of the four arsenic metabolites: inorganic As(III) and As(V), methylarsonic acid, and dimethylarsinic acid. The model consists of five tissue compartments, chosen according to arsenic affinities: liver, kidneys, lungs, skin, and others. The model is based on physiological parameters, which were scaled according to body weight. When physiological parameters were not available, the data for the model were obtained by fitting (tissue affinity, absorption rate, and metabolic rate constants). The excretions of the arsenic metabolites in urine and feces are well simulated with the model for both species. Further validation of the arsenic metabolite concentrations in the tissues and in vitro measurements of the tissue affinity constants are discussed.

Citations

Jun 30, 1998·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·M S GolubN Baumrind
Dec 12, 2003·Journal of Toxicology and Environmental Health. Part a·P Robinan GentryHarvey J Clewell
Apr 1, 2005·Journal of Toxicology and Environmental Health. Part a·P Robinan GentryHarvey J Clewell
Apr 24, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Marina V EvansHisham A El-Masri
Jul 14, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michael F HughesDavid J Thomas
Jun 3, 2014·Theoretical Biology & Medical Modelling·Sean D LawleyH Frederik Nijhout
Aug 30, 2011·Theoretical Biology & Medical Modelling·Sean D LawleyMichael C Reed
Nov 14, 1997·Toxicology and Applied Pharmacology·L L HallD J Thomas
Jul 15, 2009·Biochimie·Emmanuel CurisSimone Bénazeth
Jun 16, 2010·Regulatory Toxicology and Pharmacology : RTP·Sean M HaysKannan Krishnan
Dec 30, 2014·Reproductive Toxicology·Daniela A ParodiMary Beth Martin
Jun 19, 1998·Critical Reviews in Toxicology·E J O'Flaherty
Jul 9, 2002·Human & Experimental Toxicology·B D BeckJ F Holson
Jul 30, 2004·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Carol A Lammon, Ronald D Hood
Feb 25, 2009·Critical Reviews in Toxicology·Ulrike Schuhmacher-WolzKlaus Schneider
Jun 4, 2013·Environmental Geochemistry and Health·Violet DiacomanolisJack C Ng
Dec 16, 1997·Journal of Toxicology and Environmental Health·H J ClewellJ M Gearhart
Feb 15, 2001·Alternatives to Laboratory Animals : ATLA·E M KenyonM V Evans
Jun 10, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Dimitrios E StephanopoulosDavid D Gummin
Dec 7, 2020·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Junko Fujihara, Naoki Nishimoto
Sep 23, 1997·Toxicology and Applied Pharmacology·C Eckhoff, C C Willhite
Apr 30, 1999·Toxicology Letters·D B MenzelR N Roth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved